期刊文献+

HPLC法测定帕米膦酸二钠注射液的含量 被引量:3

Determination of content of pamidronate sodium by HPLC
暂未订购
导出
摘要 目的建立离子交换高效液相色谱法测定帕米膦酸二钠的方法。方法采用IC-Paktm Anion HR色谱柱,以2mmol.L-1硝酸溶液(用5mol.L-1硝酸溶液调节pH值至2.70)为流动相,检测波长230nm流速1.0mL.min-1,进样量30μl。结果帕米膦酸进样量在3.82~45.85μg范围内与峰面积呈良好的线性关系(r=0.9988,n=7),回收率为100.0%(RSD=1.08%,n=9)。结论建立方法操作简便,结果准确,可应用日常实验的检测。 Objective To establish an ion - exchange HPLC method for the determination of content of pamidronate disodium for injection. Methods The determination was performed on IC - Paktm Anion HR( 150mm × 4.6mm) column with 2mmol· L^-1 nitric acid (adjust pH = 2.70 with 5mol· L^-1 nitric acid) as mobile phase at a flow rate of 1.0ml· L^-1 ,the sample size was 30ul and the detection wavelength was 230nm. Results The linear range of pamidronate was 3.82 - 45. 85ug(r=0.9988,n=7). the mean recovery rate was 100.0% (RSD = 1.08% ,n =9). Conclusion The methed is convenient, accurate and suitable for the assay of pamidronate disodium injection.
作者 蔡玫 许晋星
出处 《中国热带医学》 CAS 2008年第9期1636-1637,共2页 China Tropical Medicine
关键词 离子交换高效液相色谱 帕米膦酸二钠注射液 条件优化 Ion - exchange HPLC Pamidronate disodium injection Assay
  • 相关文献

参考文献5

二级参考文献39

  • 1张根元,林力行,严相平,季靖,马文诗.EDTA间接滴定法测定帕米膦酸二钠含量[J].药学与临床研究,1997,12(3):23-24. 被引量:2
  • 2钟永祥,张祥斌.帕米膦酸二钠的临床应用进展[J].中华全科医师杂志,2005,4(1):27-29. 被引量:11
  • 3申淑景 马智勇 李醒亚.博宁引起呼吸困难2例[J].中国新药杂志,1999,8:561-561.
  • 4Boutsen Y, Jamart J, Esselinckx W, et al. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and caicium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.J Bone Miner Res. 2001.16:104-112.
  • 5Morabito N, Gaudio A, Lasco A, et al. Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postemenopausal osteoporosis. Osteoporos Int,2003,14 :500-506.
  • 6Bartram SA, Peaston RT, Rawlings DJ, et al. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Phamacol Ther,2003.18 : 1121-1127.
  • 7Senaratne SG, Pirianov G, Mansi JL. Bisphosphonates induce apoptosis in human breast cancer cell lines. J Pediatr Endocrinol Metab ,2002,15 : 163-174.
  • 8Johnston AD. Pathology of metastatic tumors in bone. Clin Orthop,1970,73:8-32.
  • 9Coleman RE, Rubens RD. Bone metastases and breast cancer.Cancer Treat Rev, 1985,12:251-270.
  • 10Horbagyi CN,Theriault RL, Porter L, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytie bone metastases . N Engl J Med , 1996, 335 : 1785-1791.

共引文献18

同被引文献42

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部